AM, R., D, V., AP, G., M, S., JL, B., M, C., . . . A, M. (2019). Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: A phase 2 study from the GELTAMO group.
Citación estilo ChicagoAM, Redondo, et al. Bendamustine As Part of Conditioning of Autologous Stem Cell Transplantation in Patients With Aggressive Lymphoma: A Phase 2 Study From the GELTAMO Group. 2019.
Cita MLAAM, Redondo, et al. Bendamustine As Part of Conditioning of Autologous Stem Cell Transplantation in Patients With Aggressive Lymphoma: A Phase 2 Study From the GELTAMO Group. 2019.
Precaución: Estas citas no son 100% exactas.